Albarracin C - Search Results

1

TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.

Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Among authors: albarracin c. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748 Free article.

2

Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer.

Liu J, Albarracin CT, Chang KH, Thompson-Lanza JA, Zheng W, Gershenson DM, Broaddus R, Luthra R. Liu J, et al. Mod Pathol. 2004 Jan;17(1):75-80. doi: 10.1038/modpathol.3800017. Mod Pathol. 2004. PMID: 14631366 Free article.

3

Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.

Cai KQ, Albarracin C, Rosen D, Zhong R, Zheng W, Luthra R, Broaddus R, Liu J. Cai KQ, et al. Among authors: albarracin c. Hum Pathol. 2004 May;35(5):552-9. doi: 10.1016/j.humpath.2003.12.009. Hum Pathol. 2004. PMID: 15138928

4

Expression of sigma 1 receptor in human breast cancer.

Wang B, Rouzier R, Albarracin CT, Sahin A, Wagner P, Yang Y, Smith TL, Meric-Bernstam F, Marcelo Aldaz C, Hortobagyi GN, Pusztai L. Wang B, et al. Among authors: albarracin ct. Breast Cancer Res Treat. 2004 Oct;87(3):205-14. doi: 10.1007/s10549-004-6590-0. Breast Cancer Res Treat. 2004. PMID: 15528963

5

The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.

Albarracin CT, Silva EG, Malpica A, Luthra R, Liu J. Albarracin CT, et al. Oncol Rep. 2004 Dec;12(6):1217-9. Oncol Rep. 2004. PMID: 15547740

6

A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.

Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, Dunmire V, Stec J, Valero V, Sneige N, Albarracin C, Wu Y, Ross JS, Wagner P, Theriault RL, Arun B, Kuerer H, Hess KR, Zhang W, Hortobagyi GN, Pusztai L. Symmans WF, et al. Among authors: albarracin c. Endocr Relat Cancer. 2005 Dec;12(4):1059-69. doi: 10.1677/erc.1.01051. Endocr Relat Cancer. 2005. PMID: 16322343

7

Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Wang KL, et al. Clin Cancer Res. 2006 Aug 1;12(15):4598-604. doi: 10.1158/1078-0432.CCR-06-0483. Clin Cancer Res. 2006. PMID: 16899607

8

Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.

Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Huo L, et al. Cancer. 2006 Oct 15;107(8):1760-8. doi: 10.1002/cncr.22216. Cancer. 2006. PMID: 16977650 Free article.

9

Profile of Ets gene expression in human breast carcinoma.

He J, Pan Y, Hu J, Albarracin C, Wu Y, Dai JL. He J, et al. Among authors: albarracin c. Cancer Biol Ther. 2007 Jan;6(1):76-82. doi: 10.4161/cbt.6.1.3551. Cancer Biol Ther. 2007. PMID: 17172821

10

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Wang KL, et al. Cancer. 2007 Feb 15;109(4):658-67. doi: 10.1002/cncr.22445. Cancer. 2007. PMID: 17211865 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page